Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 41

Trial Status

Terminated1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02034279Phase 4Terminated
The INFECIR-2 Albumin Prevention Study
Advanced Chronic Liver DiseaseCholangitisOther Bacterial Diseases+2 more
PrincipalinvestigatorStart date: 2014-05-01

Research Network

Collaboration Network

27 collaborators·74 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Thierry Gustot

Erasme University Hospital, Brussels, Belgium

Similar
1 trials

Shared therapeutic areas:

Advanced Chronic Liver DiseaseCholangitisOther Bacterial Diseases+2 more

Worked with same sponsors:

EASL - CLIF Consortium
Collaborated on 1 trial
Similarity Score54%

Rafael Bañares

Hospital Gregorio Marañon, Madrid, Spain

Similar
1 trials

Shared therapeutic areas:

Advanced Chronic Liver DiseaseCholangitisOther Bacterial Diseases+2 more

Worked with same sponsors:

EASL - CLIF Consortium
Collaborated on 1 trial
Similarity Score54%

Frederick Nevens

University Hospitals KU, Leuven, Belgium

Similar
1 trials

Shared therapeutic areas:

Advanced Chronic Liver DiseaseCholangitisOther Bacterial Diseases+2 more

Worked with same sponsors:

EASL - CLIF Consortium
Collaborated on 1 trial
Similarity Score54%

Henning Gronbaeck

Aarhus University Hospital

Similar
1 trials

Shared therapeutic areas:

Advanced Chronic Liver DiseaseCholangitisOther Bacterial Diseases+2 more

Worked with same sponsors:

EASL - CLIF Consortium
Collaborated on 1 trial
Similarity Score54%

Alexander Gerbes

University Hospital of Munich, Germany

Similar
1 trials

Shared therapeutic areas:

Advanced Chronic Liver DiseaseCholangitisOther Bacterial Diseases+2 more

Worked with same sponsors:

EASL - CLIF Consortium
Collaborated on 1 trial
Similarity Score54%

Matthias Dollinger

University of Ulm, Heidelberg and Tübingen, Germany

Similar
1 trials

Shared therapeutic areas:

Advanced Chronic Liver DiseaseCholangitisOther Bacterial Diseases+2 more

Worked with same sponsors:

EASL - CLIF Consortium
Collaborated on 1 trial
Similarity Score54%

Jose Luis Montero

Hospital Reina Sofia, Cordoba, Spain

Similar
1 trials

Shared therapeutic areas:

Advanced Chronic Liver DiseaseCholangitisOther Bacterial Diseases+2 more

Worked with same sponsors:

EASL - CLIF Consortium
Collaborated on 1 trial
Similarity Score54%

Fin Stolze Larsen

Rigshospitalet, University of Copenhagen

Similar
1 trials

Shared therapeutic areas:

Advanced Chronic Liver DiseaseCholangitisOther Bacterial Diseases+2 more

Worked with same sponsors:

EASL - CLIF Consortium
Collaborated on 1 trial
Similarity Score54%

Agustin Albillos

Hospital Ramon y Cajal, Madrid, Spain

Similar
1 trials

Shared therapeutic areas:

Advanced Chronic Liver DiseaseCholangitisOther Bacterial Diseases+2 more

Worked with same sponsors:

EASL - CLIF Consortium
Collaborated on 1 trial
Similarity Score54%

Aide McCormick

University College of Dublin, Ireland

Similar
1 trials

Shared therapeutic areas:

Advanced Chronic Liver DiseaseCholangitisOther Bacterial Diseases+2 more

Worked with same sponsors:

EASL - CLIF Consortium
Collaborated on 1 trial
Similarity Score54%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02034279Phase 4PrincipalInvestigator

The INFECIR-2 Albumin Prevention Study

Advanced Chronic Liver DiseaseCholangitisOther Bacterial Diseases+2 more
Terminated

All 1 trials loaded